Keele Research Repository

Article

Sprigg, N, Flaherty, K, Appleton, J, Salman, R, Bereczki, D, Beridze, M, Christensen, H, Ciccone, A, Collins, R, Czlonkowska, A, Dineen, R, Duley, L, Egea-Guerrero, J, England, T, Krishnan, K, Laska, AC, Law, ZK, Ozturk, S, Pocock, S, Roberts, I, Robinson, T, Roffe, C ORCID: https://orcid.org/0000-0002-5259-6649, Seiffge, D, Scutt, P, Thanabalan, J, Werring, D, Whynes, D and Bath, P (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. The Lancet, 391 (10135). pp. 2107-2115.

Sprigg, N, Robson, K, Bath, P, Dineen, R, Roberts, I, Robinson, T, Roffe, C, Werring, D, Al-Shahi Salman, R, Pocock, S, Duley, L, England, T, Whynes, D, Ciccone, A, Laska, AC, Christensen, H, Ozturk, S, Collins, R, Bereczki, D, Egea-Guerrero, JJ, Law, ZK, Czlonkowska, A, Seiffge, D and Beredzie, M (2016) Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial. International Journal of Stroke, 11 (6). pp. 683-694.